Eric Joseph Daniels - 20 Apr 2026 Form 4 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)

Reporting relationship: Chief Development Officer
Issuer ticker: PSTV
Reported as of: 20 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Apr 2026, 17:00:04 UTC
Prior SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: Andrew Sims, as attorney-in-fact

Key filing fact

Eric Joseph Daniels filed Form 4 for PLUS THERAPEUTICS, INC. (PSTV) on 22 Apr 2026.

Key facts

This page summarizes Eric Joseph Daniels's Form 4 filing for PLUS THERAPEUTICS, INC. (PSTV).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 22 Apr 2026, 17:00.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001892943 Primary reporting owner

Daniels Eric Joseph

Relationship: Chief Development Officer
Address: 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON
Signature: Andrew Sims, as attorney-in-fact
Signature date: 22 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PSTV transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +20,000
Change %
Price: $0.000000^*
Shares after: 20,000
Date: 20 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $0.000000
Footnotes: F1

PSTV transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +20,000
Change %
Price: $0.000000^*
Shares after: 20,000
Date: 20 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $7.30
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. One third of the RSUs awarded vest on July 1, 2027, and the remainder of the RSUs vest ratably over the next eight quarters in substantially equal increments.

Footnote F2

One fourth of the options vest on April 20, 2027 and an additional 1/36th of the remaining options vest on each monthly anniversary thereafter in substantially equal increments.